Home / Stocks / Shilpa Medicare Ltd
SHILPAMED

Shilpa Medicare Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹900.7

Change

-14.6 (-1.6%)

Open

₹922.0

Prev. Close

₹915.3

Day High

₹927.9

Day Low

₹893.65

Volume Analysis

Traded

373,638

Delivered

192,301

Delivery %

51.47%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (28.0%)

Weaknesses (2)

  • •Low return on equity (9.3%)
  • •Promoter holding is falling

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹955.44 ₹941.67 ₹921.19 ₹907.42 ₹886.94 ₹873.17 ₹852.69
Fibonacci ₹941.67 ₹928.59 ₹920.5 ₹907.42 ₹894.34 ₹886.25 ₹873.17
Camarilla ₹910.12 ₹906.98 ₹903.84 ₹907.42 ₹897.56 ₹894.42 ₹891.28

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+185.17%

1 Week

-8.99%

1 Month

+6.57%

3 Months

+10.52%

6 Months

+83.72%

1 Year

+152.79%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹198.66

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

10.0%

Net margin 18.02% × asset turnover 0.37x × equity multiplier 1.5x

Company Overview

Sector

Healthcare

Market Cap

₹17,616 Cr

P/E (TTM)

55.1

ROE

9.3%

Book Value

₹141.0

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 20 Nov 2026. Not investment advice.

TopFund Analysis

Shilpa Medicare Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 63/100. The strongest factor is Financial Strength (100/100), while Valuation (10/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (28.0%); low return on equity (9.3%); promoter holding is falling. FII holding has been rising.

TopFund Score — Fundamentals Quality

63/100 — Average

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

52

Valuation

10

Cash Flow

43

Corporate Governance

51

Momentum

77

Institutional Ownership

66

Business Quality

74

Risk & Volatility

79

Liquidity

81

From Screener.in

  • +Company is expected to give good quarter
  • −Stock is trading at 6.39 times its book value
  • −The company has delivered a poor sales growth of 11.3% over past five years.
  • −Company has a low return on equity of 5.51% over last 3 years.
  • −Promoter holding has decreased over last 3 years: -9.88%

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Q2FY27 Earnings Conference Call 05 November 2026

Q2/FY2026-27 conference call recording made available on company website.

Investor Presentation for the Quarter and Half year ended 30 September 2026

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 313 287 292 293 344 319 331 321 370 410 437 466 529
Expenses + 255 222 222 222 258 239 252 231 262 296 317 330 387
Operating Profit 58 65 70 70 86 81 79 91 108 114 120 136 142
OPM % 19.0% 23.0% 24.0% 24.0% 25.0% 25.0% 24.0% 28.0% 29.0% 28.0% 27.0% 29.0% 27.0%
Other Income + 2 2 9 10 5 2 -21 6 2 -13 45 9 8
Interest 23 26 24 24 26 12 14 19 16 11 14 12 13
Depreciation 28 27 27 27 28 29 29 29 30 30 31 35 34
Profit before tax 9 14 28 29 37 42 15 50 64 61 120 98 104
Tax % 83.0% 67.0% 12.0% 51.0% 51.0% 24.0% 5.0% 5.0% 32.0% 27.0% 10.0% -3.0% 24.0%
Net Profit + 2 5 24 14 18 32 15 47 44 45 108 101 79
EPS in Rs 0 0 1 1 1 2 1 2 2 2 6 5 4
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 19 9 11 12 10 11 13 10 8 28 32 45 43

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 614 719 779 789 733 908 899 1,141 1,046 1,146 1,281 1,535 1,842
Expenses + 485 566 614 634 585 688 718 940 947 907 962 1,100 1,329
Operating Profit 129 153 165 155 148 219 181 202 99 239 319 435 513
OPM % 21.0% 21.0% 21.0% 20.0% 20.0% 24.0% 20.0% 18.0% 9.0% 21.0% 25.0% 28.0% 28.0%
Other Income + 5 5 15 22 33 17 90 21 17 15 -8 39 50
Interest 4 7 3 3 4 5 22 41 59 92 76 59 49
Depreciation 21 29 31 37 42 44 54 80 96 108 113 120 130
Profit before tax 108 122 146 137 136 188 195 102 -38 54 122 295 383
Tax % 33.0% 19.0% 29.0% 25.0% 19.0% 18.0% 25.0% 41.0% -19.0% 41.0% 36.0% 18.0% —
Net Profit + 73 99 104 103 110 155 146 61 -31 32 78 243 332
EPS in Rs 5 7 7 6 7 10 9 3 -2 2 4 12 17
Dividend Payout % 6.0% 4.0% 4.0% 5.0% 7.0% 6.0% 6.0% 16.0% 0.0% 0.0% 12.0% 5.0% —
Sales growth 7 17 8 1 -7 24 -1 27 -8 10 12 20 37

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 539 639 979 1,077 1,189 1,321 1,471 1,814 1,775 1,800 2,353 2,572 2,738
Borrowings + 189 221 241 191 194 390 846 683 798 937 588 660 666
Other Liabilities + 169 194 244 223 218 270 308 370 323 347 360 455 714
Total Liabilities 905 1,062 1,472 1,499 1,610 1,989 2,632 2,876 2,904 3,093 3,311 3,706 4,138
Fixed Assets + 316 580 492 534 558 650 1,111 1,342 1,368 1,385 1,418 1,593 2,165
CWIP 222 95 141 210 429 666 541 506 655 719 822 884 520
Investments 66 53 253 140 2 10 21 34 43 40 35 58 67
Other Assets + 301 334 587 615 621 662 959 993 838 950 1,037 1,170 1,386
Total Assets 905 1,062 1,472 1,499 1,610 1,989 2,632 2,876 2,904 3,093 3,311 3,706 4,138
Equity Capital 8 8 8 8 8 8 8 9 9 9 10 20 20

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 69 129 37 45 147 124 47 105 180 137 132 342
Cash from Investing Activity + -196 -106 -257 -10 -196 -290 -404 -286 -232 -171 -198 -339
Cash from Financing Activity + 136 -20 313 -61 10 176 436 83 46 47 63 14
Net Cash Flow 9 3 93 -26 -39 10 79 -98 -7 13 -3 17
Free Cash Flow -74 12 -79 -92 -151 -220 -302 -226 -46 -48 -111 -28
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 73 103 43 55 123 76 52 69 215 74 56 93

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 50.01% → 40.13%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 41.41% 42.71% 38.91% 37.9% 37.59% 37.25% 37.1% 37.18% 40.56% 40.21% 40.42% 39.49%
Promoters 50.01% 50.01% 44.39% 44.33% 44.23% 44.23% 44.23% 44.23% 40.13% 40.13% 40.13% 40.13%
FII 8.52% 5.63% 9.08% 9.59% 9.9% 10.97% 11.19% 10.92% 10.97% 11.07% 11.39% 12.11%
DII 0.06% 1.65% 7.61% 8.18% 8.27% 7.55% 7.46% 7.67% 8.34% 8.58% 8.05% 8.26%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Shilpa Medicare Ltd (this stock) 17,616 55.1 6.39 9.3%
Pfizer Ltd 17,601 115.0 12.74 19.8%
Cohance Lifesciences Ltd 17,511 359.0 4.49 4.89%
Dr Agarwals Health Care L 17,460 97.5 7.8 6.41%
Alivus Life Sciences Ltd 17,803 50.6 — —
Caplin Point Lab Ltd. 17,863 25.9 4.58 20.9%
Syngene International Ltd 17,935 67.5 3.7 7.78%

Which Mutual Funds Hold Shilpa Medicare Ltd?

Frequently Asked Questions about Shilpa Medicare Ltd

Community Sentiment

What are other investors saying about Shilpa Medicare Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.